Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer

BACKGROUND: Pancreatic cancer remains one of the deadliest cancers due to lack of early detection and absence of effective treatments. Gemcitabine, the current standard-of-care chemotherapy for pancreatic cancer, has limited clinical benefit. Treatment of pancreatic cancer cells with gemcitabine has...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yip-Schneider, Michele T, Wu, Huangbing, Stantz, Keith, Agaram, Narasimhan, Crooks, Peter A, Schmidt, C Max
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3672012/
https://ncbi.nlm.nih.gov/pubmed/23590467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-194
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares